Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Sep 6, 2021; 9(25): 7358-7364
Published online Sep 6, 2021. doi: 10.12998/wjcc.v9.i25.7358
Table 1 Analysis of the basic clinical data in between-group patients, mean ± SD or n (%)
Factor
Young group, n = 55
Middle-aged group, n = 55
t/X2
P value
Age36.12 ± 4.2571.36 ± 5.4337.90120.0000
Diabetes8 (14.54)35 (63.63)27.83410.0000
Hypertension9 (16.36)39 (70.90)33.26610.0000
Smoking history20 (36.36)31 (56.36)4.42340.0354
BMI in kg/m227.35 ± 3.3325.08 ± 2.194.22380.0001
Family history of CHD4 (7.27)12 (21.81)4.68090.0305
Hyperuricemia3 (5.45)23 (4.18)20.14650.0000
Dyslipidemia20 (36.36)22 (40.00)0.15410.6946
Myocardial infarction17 (30.90)30 (54.54)6.27830.0122
Drinking history19 (34.54)7 (12.72)7.25270.0070
Stroke history2 (3.63)6 (10.90)2.15690.1419
Table 2 Analysis of coronary artery lesion characteristics in between-group patients, n (%)
Group
Gensini score > 50
Collateral circulation
MVD
DVD
SVD
Right coronary artery
Left main coronary artery
Young, n = 5510 (18.18)11 (20.00)6 (10.90)8 (14.54)17 (30.90)10 (18.18)2 (3.63)
Middle-aged, n = 5524 (43.63)23 (41.81)19 (34.54)17 (30.90)7 (12.72)22 (40.00)8 (14.54)
X28.34376.13008.74824.19295.32956.34623.9600
P value0.00380.01320.00300.04050.02090.01170.0465
Table 3 Factor analysis of blood lipid related index in between-group patients (mean ± SD)
Group
Serum uric acid, μmol/L
Fibrinogen, g/L
HDL-C, mmol/L
LDL-C, mmol/L
Triacylglycerol, mmol/L
Total cholesterol, mmol/L
Young, n = 55285 ± 173.22 ± 0.951.12 ± 0.362.81 ± 0.462.13 ± 0.664.60 ± 0.57
Middle-aged, n = 55386 ± 192.75 ± 0.711.02 ± 0.352.41 ± 0.231.97 ± 0.534.13 ± 0.41
X229.37962.93891.47705.76801.40184.9642
P value0.00000.00400.14260.00000.16380.0000